0.6445
price up icon1.46%   0.0093
 
loading
Schlusskurs vom Vortag:
$0.6352
Offen:
$0.6399
24-Stunden-Volumen:
8,610
Relative Volume:
0.08
Marktkapitalisierung:
$17.85M
Einnahmen:
$8.59M
Nettoeinkommen (Verlust:
$-17.07M
KGV:
-1.0566
EPS:
-0.61
Netto-Cashflow:
$-21.90M
1W Leistung:
+0.00%
1M Leistung:
+21.31%
6M Leistung:
-14.07%
1J Leistung:
-50.80%
1-Tages-Spanne:
Value
$0.6399
$0.66
1-Wochen-Bereich:
Value
$0.60
$0.6669
52-Wochen-Spanne:
Value
$0.4801
$1.74

Durect Corp Stock (DRRX) Company Profile

Name
Firmenname
Durect Corp
Name
Telefon
(408) 777-1417
Name
Adresse
10240 BUBB ROAD, CUPERTINO, CA
Name
Mitarbeiter
14
Name
Twitter
@DURECTCorp
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
DRRX's Discussions on Twitter

Vergleichen Sie DRRX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
DRRX
Durect Corp
0.6556 17.85M 8.59M -17.07M -21.90M -0.61
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
16.10 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
157.84 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.38 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.49 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.73 20.17B 16.54B -1.64B 749.00M -1.45

Durect Corp Stock (DRRX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2020-10-30 Eingeleitet Chardan Capital Markets Buy
2020-10-12 Eingeleitet ROTH Capital Buy
2020-07-31 Eingeleitet Oppenheimer Outperform
2020-01-31 Eingeleitet B. Riley FBR Buy
2019-11-18 Fortgesetzt Cantor Fitzgerald Overweight
2019-09-06 Eingeleitet Cantor Fitzgerald Overweight
2018-03-06 Hochstufung H.C. Wainwright Neutral → Buy
2017-10-20 Herabstufung H.C. Wainwright Buy → Neutral
2017-10-20 Bestätigt Laidlaw Buy
2017-10-20 Herabstufung Stifel Buy → Hold
2017-07-12 Hochstufung Stifel Hold → Buy
2017-02-28 Fortgesetzt H.C. Wainwright Buy
2016-04-25 Eingeleitet Rodman & Renshaw Buy
2015-05-01 Bestätigt Cantor Fitzgerald Buy
2015-05-01 Bestätigt Stifel Buy
2013-03-25 Eingeleitet Stifel Buy
2012-11-01 Herabstufung C.K. Cooper Buy → Hold
2012-08-17 Eingeleitet C.K. Cooper Buy
2009-06-23 Eingeleitet Caris & Company Buy
2009-03-26 Eingeleitet Wedbush Morgan Hold
Alle ansehen

Durect Corp Aktie (DRRX) Neueste Nachrichten

pulisher
Jun 10, 2025

Allay’s $57.5M extends postsurgical pain relief with ATX-101 - BioWorld MedTech

Jun 10, 2025
pulisher
Jun 10, 2025

Jane Street Group LLC Purchases 28,486 Shares of DURECT Co. (NASDAQ:DRRX) - Defense World

Jun 10, 2025
pulisher
May 23, 2025

Durect Corp stock hits 52-week low at $0.52 amid market challenges - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Durect Corp stock hits 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 22, 2025

Durect says ‍on July 24, Impax Laboratories terminated asset transfer and license agreement dated Jan. 3, 2014 - Reuters

May 22, 2025
pulisher
May 22, 2025

DURECT (NASDAQ:DRRX) Now Covered by Analysts at StockNews.com - Defense World

May 22, 2025
pulisher
May 15, 2025

Durect: Q1 Earnings Snapshot - New Haven Register

May 15, 2025
pulisher
May 14, 2025

DURECT (DRRX) Q1 Revenue Surpasses Estimates, Focuses on Phase 3 Trial Funding | DRRX Stock News - GuruFocus

May 14, 2025
pulisher
May 13, 2025

Durect Corp Q1 2025 Earnings: EPS at -$0.13 Misses Estimate, Rev - GuruFocus

May 13, 2025
pulisher
May 13, 2025

DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - PR Newswire

May 13, 2025
pulisher
May 10, 2025

DURECT (DRRX) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
Apr 23, 2025

Durect Corp stock hits 52-week low at $0.69 amid market challenges By Investing.com - Investing.com South Africa

Apr 23, 2025
pulisher
Apr 23, 2025

Durect Corp stock hits 52-week low at $0.69 amid market challenges - Investing.com

Apr 23, 2025
pulisher
Apr 22, 2025

Form 8-KCurrent report - ADVFN

Apr 22, 2025
pulisher
Apr 21, 2025

DURECT Co. (NASDAQ:DRRX) Sees Large Decline in Short Interest - Defense World

Apr 21, 2025
pulisher
Apr 20, 2025

DURECT (NASDAQ:DRRX) Now Covered by StockNews.com - Defense World

Apr 20, 2025
pulisher
Apr 12, 2025

StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX) - Defense World

Apr 12, 2025
pulisher
Apr 09, 2025

Durect Corp stock hits 52-week low at $0.7 amid market challenges - Investing.com Canada

Apr 09, 2025
pulisher
Apr 04, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated at StockNews.com - Defense World

Apr 04, 2025
pulisher
Mar 31, 2025

DURECT Corporation (NASDAQ:DRRX) Q4 2024 Earnings Call Transcript - MSN

Mar 31, 2025
pulisher
Mar 28, 2025

Here's Why We're A Bit Worried About DURECT's (NASDAQ:DRRX) Cash Burn Situation - Yahoo Finance

Mar 28, 2025
pulisher
Mar 27, 2025

DURECT Corporation’s Earnings Call Highlights Cost Cuts and Breakthrough Potential - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp Q4 2024 Earnings: EPS of $0.25 Surpasses Estimates, Revenue Falls Short at $0.5 Million - GuruFocus

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic Focus Amid Financial Challenges - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Durect Corp (DRRX) Q4 2024 Earnings Call Highlights: Strategic F - GuruFocus.com

Mar 27, 2025
pulisher
Mar 26, 2025

Durect: Q4 Earnings Snapshot - MySA

Mar 26, 2025
pulisher
Mar 26, 2025

Durect reports Q4 cont ops EPS (6c), consensus (2c) - TipRanks

Mar 26, 2025
pulisher
Mar 26, 2025

Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings call transcript: Durect’s Q4 2024 revenue drops as focus shifts to key drug - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

DURECT Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025
pulisher
Mar 26, 2025

DURECT Transforms Business: $17.5M Asset Sale, NEJM Evidence Validates Key Drug Program - Stock Titan

Mar 26, 2025
pulisher
Mar 26, 2025

Earnings Scheduled For March 26, 2025 - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - PR Newswire

Mar 26, 2025
pulisher
Mar 25, 2025

What To Expect From Durect Corp (DRRX) Q4 2024 Earnings - GuruFocus

Mar 25, 2025
pulisher
Mar 20, 2025

ARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance

Mar 20, 2025
pulisher
Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update - Quantisnow

Mar 19, 2025

Finanzdaten der Durect Corp-Aktie (DRRX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$14.39
price up icon 0.81%
$8.9773
price up icon 0.45%
$127.30
price up icon 1.67%
$291.00
price up icon 1.03%
drug_manufacturers_specialty_generic RDY
$14.98
price down icon 0.30%
$16.73
price down icon 0.24%
Kapitalisierung:     |  Volumen (24h):